Quick Answer
BIODESIX INC reported Common Stock Shares Outstanding of 8.25 million shares for the year ending 2025.
- BIODESIX INC showed an increase of +13.5% in Common Stock Shares Outstanding from 2024 to 2025.
- This data is from BIODESIX INC's annual report (Form 10-K), filed with the SEC on February 26, 2026.
- XBRL data for this metric is available from 2019 to 2025 (7 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q3 2020: 289,508 shares | Q1 2021: 26.79 million shares | Q2 2021: 26.95 million shares | Q3 2021: 27.02 million shares | Q1 2022: 31.89 million shares | Q2 2022: 39.98 million shares | Q3 2022: 41.19 million shares | Q1 2023: 77.98 million shares | Q2 2023: 78.61 million shares | Q3 2023: 88.32 million shares | Q1 2024: 97.16 million shares | Q2 2024: 145.15 million shares | Q3 2024: 145.47 million shares | Q1 2025: 146.44 million shares | Q2 2025: 146.58 million shares | Q3 2025: 7.95 million shares.
- Over the full 7 years of available data (2019 to 2025), BIODESIX INC's Common Stock Shares Outstanding has grown by 3,137.5%.
- Historical annual values: Fiscal year 2025: 8.25 million shares | Fiscal year 2024: 7.27 million shares | Fiscal year 2023: 96.24 million shares | Fiscal year 2022: 77.61 million shares | Fiscal year 2021: 30.79 million shares | Fiscal year 2020: 26.56 million shares | Fiscal year 2019: 254,918 shares.
- Data sourced from SEC EDGAR public filings as of August 9, 2026.
Last verified: